Mupirocin Ointment
Product Images NDC 68462-180

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mupirocin (NDC 68462-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

FDA Label Image

Glenmark (Glenmark)

FDA Label Image

Image 01

FDA Label Image

Mupirocin Carton

Mupirocin Carton
This is a product description for Mupirocin ointment containing 2% USP manufactured by Glenmark Pharmaceuticals Ltd. in India and marketed by Glenmark Pharmaceuticals Inc in the USA. The medication is for dermatologic use only and is not intended for ophthalmic use. Each gram contains 20mg of mupirocin in a polyethylene glycol ointment base. The recommended dosage is to apply a small amount of ointment to the affected area three times daily. Clinical response should be evaluated within 3 to 5 days. The prescribing information should be consulted for more information. The product should be stored within the recommended temperature range.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.